The Promise of Chimeric Antigen Receptor Engineered T cells in the Treatment of Hematologic Malignancies

Por Nagle, Sarah J., Garfall, Alfred L., Stadtmauer, Edward A.
Publicado no Cancer J (2016)

Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis

Por Olin, Rebecca L., Nichols, Kim E., Naghashpour, Mojdeh, Wasik, Mariusz, Shelly, Brenda, Stadtmauer, Edward A., Vogl, Dan T.
Publicado em 2008

Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs

Por Tanhehco, Yvette C., Adamski, Jill, Sell, Mary, Cunningham, Kathleen, Eisenmann, Christa, Magee, Deborah, Stadtmauer, Edward A., O’Doherty, Una
Publicado em 2010

Safety and Efficacy of Upfront Plerixafor + G-CSF vs. Placebo + G-CSF for Mobilization of CD34(+) Hematopoietic Progenitor Cells in Patients ≥60 and <60 Years of Age with Non-Hodgk...

Por Micallef, Ivana N., Stiff, Patrick J., Stadtmauer, Edward A., Bolwell, Brian J., Nademanee, Auayporn P., Maziarz, Richard T., Partisano, Angela M., Marulkar, Sachin, DiPersio, John F.
Publicado no Am J Hematol (2013)

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

Por Dimopoulos, Meletios, Alegre, Adrian, Stadtmauer, Edward A, Goldschmidt, Hartmut, Zonder, Jeffrey A, de Castro, Carlos M, Masliak, Zvenyslava, Reece, Donna, Olesnyckyj, Marta, Yu, Zhinuan, Weber, Donna M
Publicado em 2010

Anatomy of a Successful Practice-Changing Study: A Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group Collaboration

Por Giralt, Sergio, McCarthy, Philip L, Anderson, Kenneth C., Carter, Shelly L, Richardson, Paul G., Rajkumar, S. Vincent, Laport, Ginna G., Stadtmauer, Edward A., Pasquini, Marcelo C, Horowitz, Mary M.
Publicado no Biol Blood Marrow Transplant (2013)

Unrelated Donors are Associated with Improved Relapse Free Survival Compared to Related Donors in Patients with Myelodysplastic Syndrome Undergoing Reduced Intensity Allogeneic Ste...

Por Yam, Clinton, Crisalli, Lisa, Luger, Selina M., Loren, Alison W., Hexner, Elizabeth O., Frey, Noelle V., Mangan, James K., Gao, Amy, Stadtmauer, Edward A., Porter, David L., Reshef, Ran
Publicado no Am J Hematol (2016)

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transpl...

Por Vose, Julie M., Carter, Shelly, Burns, Linda J., Ayala, Ernesto, Press, Oliver W., Moskowitz, Craig H., Stadtmauer, Edward A., Mineshi, Shin, Ambinder, Richard, Fenske, Timothy, Horowitz, Mary, Fisher, Richard, Tomblyn, Marcie
Publicado em 2013

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

Por Stadtmauer, Edward A, Weber, Donna M, Niesvizky, Ruben, Belch, Andrew, Prince, Miles H, San Miguel, Jesús F, Facon, Thierry, Olesnyckyj, Marta, Yu, Zhinuan, Zeldis, Jerome B, Knight, Robert D, Dimopoulos, Meletios A
Publicado em 2009

Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease

Por Rager, Alison, Frey, Noelle, Goldstein, Steven C, Reshef, Ran, Hexner, Elizabeth O, Loren, Alison, Luger, Selina M, Perl, Alexander, Tsai, Donald, Davis, Jennifer, Vozniak, Michael, Smith, Jacqueline, Stadtmauer, Edward A, Porter, David L
Publicado em 2010

Low Risk of Chronic Graft Versus Host Disease and Relapse Associated with T-Cell Depleted Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission:...

Por Devine, Steven M., Carter, Shelly, Soiffer, Robert J, Pasquini, Marcelo C., Hari, Parameswaran N, Stein, Anthony, Lazarus, Hillard M., Linker, Charles, Stadtmauer, Edward A., Alyea, Edwin P., Keever-Taylor, Carolyn A., O'Reilly, Richard J
Publicado em 2011

Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multi-Center Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BM...

Por Keever-Taylor, Carolyn A., Devine, Steven M., Soiffer, Robert J, Mendizabal, Adam, Carter, Shelly, Pasquini, Marcelo C., Hari, Parameswaran N, Stein, Anthony, Lazarus, Hillard M., Linker, Charles, Goldstein, Steven C., Stadtmauer, Edward A., O'Reilly, Richard J
Publicado em 2011

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

Por Stadtmauer, Edward A., Sullivan, Keith M., Marty, Francisco M., Dadwal, Sanjeet S., Papanicolaou, Genovefa A., Shea, Thomas C., Mossad, Sherif B., Andreadis, Charalambos, Young, Jo-Anne H., Buadi, Francis K., El Idrissi, Mohamed, Heineman, Thomas C., Berkowitz, Elchonon M.
Publicado no Blood (2014)

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma

Por Shah, Jatin J., Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, Brian G. M.
Publicado no Blood (2015)

Early donor chimerism levels predict relapse and survival after allogeneic stem-cell transplantation with reduced intensity conditioning

Por Reshef, Ran, Hexner, Elizabeth O., Loren, Alison W., Frey, Noelle V., Stadtmauer, Edward A., Luger, Selina M., Mangan, James K., Gill, Saar I., Vassilev, Pavel, Lafferty, Kathryn A., Smith, Jacqueline, Van Deerlin, Vivianna M., Mick, Rosemarie, Porter, David L.
Publicado em 2014

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials

Por Berry, Donald A., Ueno, Naoto T., Johnson, Marcella M., Lei, Xiudong, Caputo, Jean, Smith, Dori A., Yancey, Linda J., Crump, Michael, Stadtmauer, Edward A., Biron, Pierre, Crown, John P., Schmid, Peter, Lotz, Jean-Pierre, Rosti, Giovanni, Bregni, Marco, Demirer, Taner
Publicado no J Clin Oncol (2011)

Lenalidomide Maintenance for High Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation

Por Alsina, Melissa, Becker, Pamela S., Zhong, Xiaobo, Adams, Alexia, Hari, Parameswaran, Rowley, Scott, Stadtmauer, Edward A., Vesole, David H., Logan, Brent, Weisdorf, Daniel, Qazilbash, Muzaffar, Popplewell, Leslie L., McClune, Brian, Bensinger, William, Riches, Marcie, Giralt, Sergio A., Pasquini, Marcelo C.
Publicado no Biol Blood Marrow Transplant (2014)

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma

Por Chen, Christine, Reece, Donna E, Siegel, David, Niesvizky, Ruben, Boccia, Ralph V, Stadtmauer, Edward A, Abonour, Rafat, Richardson, Paul, Matous, Jeffrey, Kumar, Shaji, Bahlis, Nizar J, Alsina, Melissa, Vescio, Robert, Coutre, Steven E, Pietronigro, Dennis, Knight, Robert D, Zeldis, Jerome B, Rajkumar, Vincent
Publicado em 2009

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

Por Reshef, Ran, Luger, Selina M., Hexner, Elizabeth O., Loren, Alison W., Frey, Noelle V., Nasta, Sunita D., Goldstein, Steven C., Stadtmauer, Edward A., Smith, Jacqueline, Bailey, Sarah, Mick, Rosemarie, Heitjan, Daniel F., Emerson, Stephen G., Hoxie, James A., Vonderheide, Robert H., Porter, David
Publicado em 2012

Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis

Por Cook, Rachel J., Wang, Zhiwei, Arora, Mukta, Lazarus, Hillard M., Kasow, Kimberly A., Champagne, Martin A., Saber, Wael, van Besien, Koen M., Hale, Gregory A., Copelan, Edward A., Elmongy, Mohamed, Ueno, Naoto T., Horn, Biljana N., Slavin, Shimon, Bishop, Michael R., Stadtmauer, Edward A.
Publicado em 2012